New York, New York 10065


A thorough infertility evaluation commonly involves determining whether a woman's fallopian tubes are patent. The two most often utilized methods of evaluating the fallopian tubes are hysterosalpingogram (taking an X-ray of the pelvis after injecting dye through the uterus and fallopian tubes) and laparoscopic chromopertubation (a surgical procedure in which dye is visualized passing through the fallopian tubes). The FemVue Saline-Air device is a new method of assessing tubal patency. The device utilizes a mixture of saline and air bubbles that can be seen passing through the fallopian tubes by ultrasound. FemVue can be efficiently performed in a physician's office and is minimally invasive. Unlike hysterosalpingogram and laparoscopic chromopertubation, it does not carry the risks of anesthesia or surgery, and doesn't expose the patient to radiation or contrast. It does, like the other two methods, carry a small risk of infection. This study will involve using the FemVue device on patients under anesthesia in the operating room before they undergo scheduled laparoscopic chromopertubation, the gold standard for evaluating tubal patency. The two methods will be compared to determine the accuracy of the FemVue device.

Study summary:

Subjects who agree to participate will have their tubes evaluated by using the FemVue Saline-Air device and laparoscopic chromopertubation.


Inclusion Criteria: - Pts ages 18-45 undergoing planned diagnostic laparoscopy with chromopertubation. Exclusion Criteria: - Adnexal mass > 3.5cm or uterine size greater than 10 wks



Primary Contact:

Principal Investigator
Steven Spandorfer, MD
Weill Medical College of Cornell University

Mitasha C. Joseph, RN, MPA
Phone: 646-962-3382

Backup Contact:

Rodriq E. Stubbs, NP
Phone: 646-962-3276

Location Contact:

New York, New York 10065
United States

Mitasha C Joseph, RN, MPA
Phone: 646-962-3382

Site Status: Recruiting

Data Source:

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.